PHLDA2 and osteosarcoma: The functional interaction between RanBP9 and TSSC3 directly regulates anoikis resistance and metastasis, and provides a biological basis for further exploration of the therapeutic significance of dual targeting RanBP9 and TSSC3 in osteosarcoma.